US Pharma MarketingBoston Scientific funnels $1.5B into MiRus, with option to buy TAVR system
Acquisitive Boston Scientific is making deals again with a major investment play into a private medtech with an option to snap up exclusive rights to its Transcatheter Aortic Valve Replacement (TAV Acquisitive Boston Scientific is making deals again with a major investment play into a private medtech with an option to snap up exclusive rights to its Transcatheter Aortic Valve Replacement system. Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Biologics Clinical Development Ophthalmology Cell & Gene Therapy Drug Development Small Molecule Research & Development…
Acquisitive Boston Scientific is making deals again with a major investment play into a private medtech with an option to snap up exclusive rights to its Transcatheter Aortic Valve Replacement system.
Source: FierceBiotech